Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
- Status
- COMPLETED
- Phase
- NA
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
- Status
- WITHDRAWN
- Phase
- N/A
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE2
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2